A Novel Diagnostic Nomogram for Noninvasive Evaluating Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection

Table 2

Comparison of patients’ baseline characteristics and clinical data between significant liver fibrosis and nonsignificant liver fibrosis groups in training dataset.

Characteristics	Nonsignificant liver fibrosis	Significant liver fibrosis
	(%)	(%)
Gender
Male	134 (64.11)	103 (70.55)	0.205
Female	75 (35.89)	43 (29.45)
Age (yrs)			0.030
LSM (kPa)			<0.001
Laboratory data
ALT (IU/L)			0.376
AST (IU/L)			0.009
TBIL (μmol/L)			0.059
DBIL (μmol/L)			0.002
ALP (IU/L)			0.001
GGT (IU/L)			<0.001
CHE (IU/L)			0.001
TP (g/L)			0.438
ALB (g/L)			0.004
GLO (g/L)			0.059
WBC (×10^9/L)			0.260
RBC (×10^12/L)			0.901
HGB (g/L)			0.703
PLT (×10^9/L)			<0.001
PT (S)			<0.001